You are worth tens of billions before you come to the system?

At the end of the meeting, Lin Zitai left behind the group's president Parks and financial director Cole, as well as several people who wanted to eat.

"The total funding for this plan requires US$1000 billion. Novartis will contribute US$400 billion. You guys will discuss how to allocate the remaining US$600 billion."

Faced with Merck, which has a market value of 4200 billion, only US$400 billion is not enough, and more funds are needed.

Lin Zitai initially set an initial price of US$1000 billion, and the three parties will jointly invest to establish a specialized subsidiary.

Saito Victory replied without thinking: "We jointly invested US$500 billion with the Mitsui Group."

He had worries before, but after seeing the data of the two drugs, all worries were thrown away.

In both data sets, the most noteworthy focus is not on how powerful the medicine is, but on the product pricing of K medicine.

The K drug produced by Prince Group only costs 65 yuan per injection, which is [-] times cheaper than Merck.

Lin Zitai wants to seize the market through low prices and attack Merck like Novartis. This pricing is understandable.

But the key lies in the follow-up. After taking over Novartis, Lin Zitai took out the agency rights of hair serum and two drugs to set a common goal and appease everyone's emotions.

But after taking over Merck,

What will Lin Zitai come up with?
  Magic strength, slow-grain medicine, hair growth hormone, K medicine, nine prices, and even the elixir of life will be taken out later.

He will only be surprised, but not too surprised.

Saito Victory did not believe that Lin Zitai had no backup plan. If there was no backup plan, Merck would not be able to be fully controlled, and the merger plan would be meaningless.

This is what he cares about!

Lee Jae-yong looked as usual, smiling but not smiling: "Mr. Saito, Mr. Aoi, do we Samsung only have a share of 100 billion US dollars? You are too overbearing."

Although he also admitted that Japan's national power is indeed stronger than their Han country, it does not mean that their Samsung Group is weaker than Mitsui Group and Dai-ichi Life.

The two of them jointly invested 500 billion US dollars, leaving only 100 billion US dollars for him. They obviously looked down on him.

I saw that the two sides had been discussing for a long time, with all kinds of quarrels and sarcastic remarks, but they had not come up with a solution.

Lin Zitai realized that it was a wrong decision to let them discuss it themselves, so he tried to smooth things over and said: "Mitsui Group and Dai-ichi Life jointly subscribed for 350 billion, and Samsung Group alone contributed 250 billion. What do you think?"

He did not dare to let Dai-ichi Life and Mitsui Group have an exclusive share of 500 billion, because the combined share of both parties was already greater than his, even if the two companies jointly subscribed.

To acquire Merck, Novartis must occupy a dominant position. This is a hard condition and the collective appeal of shareholders.

Saito Shengli frowned and was dissatisfied with this plan: "Mr. Lin, in this case, we and Mitsui Group will only share 175 billion equally. This distribution is not reasonable."

Lin Zitai called Deng Jiahao, took out his computer, and played a video: "If you don't agree, you can refuse, don't force it."

The video shows a date in mid-July last year.

A chimpanzee showed intelligence beyond his own kind after being injected with blue medicine...

Lin Zitai said softly: "I wonder if you have seen the neuron paper published by Mr. Ye Wudao Ye in our "Biological Times" in January this year?"

"Mr. Ye has been employed by our Prince Group and has become the chief scientist of our group."

"The nine-valent vaccine and k-drug are the latest products developed by his team. Now he is specializing in neuron projects and has achieved certain scientific research results..."

Saito was stunned for a moment, his face flushed and he hurriedly asked: "Mr. Lin, do you have any scientific research results that you can tell me?"

He guessed right. Lin Zitai indeed had a backup plan. Neurons have always been the most mysterious field in the history of human medicine.

Ye Wudao's several neuron papers have been regarded as treasures by more and more academic experts as time goes by.

There are even fanatical believers who claim that if in this era, humans will make a major breakthrough in the field of brain neurons.

So the person who created this era must be Ye Wudao. The influence of several papers is no less than that of Newtonian mechanics.

Saito Victory was scratching his head. He wanted to know what scientific research results there were. Is it treating insomnia and anxiety, mental suppression, or Alzheimer's disease?
  No matter which one is good, there is a huge market audience in countries around the world.

Lin Zitai smiled calmly: "I'm sorry, Mr. Saito, it's not convenient to tell you right now."

This sweet spot was left to Merck, giving them a little advance notice, just to keep them from working hard.

He is not Zhao Xiaoyou, and no one can play with anything under his nose.

Saito smiled wryly and expected that this would be the case: "No problem, we have no objection to this distribution plan."

Lin Zitai turned to look at Li Zairong: "President Li, what about you?" Li Zairong looked complicated: "It doesn't make sense."

He subconsciously looked at Saito Shengli, and both of them could see the bitterness in the other's eyes.

If nothing else, Lin Zitai once again took the dominant position in this project.

The video of just a few minutes has become a lingering obsession in the minds of everyone present.

For this obsession, they could only cooperate with Lin Zitai and launch an offensive against Merck.

…………

In the evening of the same day, Novartis Group issued an announcement.

A billion-dollar dividend at the end of the year, a 30% salary increase for all employees, and a final US$400 billion financing plan.

The three pieces of news announced are more important than the last, especially the final US$400 billion financing plan.

At least two important messages were revealed to the outside world. Lin Zitai took over Novartis and successfully took power. He is no longer a major shareholder in name only, otherwise the three plans would not be passed.

Secondly, this guy is probably going to cause trouble again.

400 billion US dollars, a full 2740 billion yuan.

Compared with Novartis, the funds raised are more than [-] billion, and I don’t know who the next lucky person will be.

However, netizens have always been very resourceful. Through various clues, they quickly concluded that Merck was probably the next target.

Because according to informed sources, Prince Group has a new drug for the treatment of tumors, which passed the review of the Food and Drug Administration yesterday.

Drugs related to the treatment of tumors are inseparable from Merck's divine K-drug, and the results are self-evident.

However, financial experts are not optimistic about the US$400 billion financing plan.

Because Novartis Group's credit rating is only C, it is only one step away from Lehman Brothers and Luckin Coffee, which have experienced thunderstorms. It basically declares that Western capital will not easily raise funds.

But experts dare not speak too fully. Lin Zitai has created too many miracles. The specific situation will depend on the content of the road show.

Because it was also [-]:[-] in the evening, and the U.S. stock market on the other side of the ocean opened.

Merck's opening gapped 5 points, and its market value of US$4200 billion evaporated US$210 billion in an instant.

A large amount of funds fled, or short positions were established.

Lin Zitai's influence is not limited to China. He is like a combination of Buffett and Soros. When he sneezes, the international financial market will tremble.

.........

The next morning, Lin Zitai flew to the capital and met the Vice Minister of Foreign Affairs through the introduction of Dai Chunsheng.

Most of the experts on the Internet are talking nonsense, but some of them are indeed genuine, and they have predicted in advance that Lin Zitai will definitely hold a road show or promotion meeting this time.

Novartis is not like Prince Group, which is wholly owned by Lin Zitai. Lin Zitai's credit is guaranteed and his character is even better.

On the other hand, Novartis has dropped from a market value of US$[-] billion at its peak last year to more than US$[-] billion now. It is still controlled by Lin Zitai and only has a C-class credit rating.

If you don't hold road shows or promotion meetings to explain to investors the use of funds and future plans, the US$400 billion financing plan is bound to fail.

To this end, Lin Zitai, Parks and Cole worked out plans for four promotion meetings overnight, spanning four countries.

The first stop is determined to be Xiangjiang, followed by Seoul in Hanguo, then Tokyo in Japan, and finally New York in the United States.

Because the last scene was scheduled to be on Wall Street in Manhattan, Lin Zitai hoped to go with the diplomatic delegation.

Back in Seoul, he dared to point at the vice president of Samsung and almost said that Samsung was a dog raised by the United States. It was understandable that they wanted to break free from the shackles of the dog chain...

It was because Lin Zitai knew that the distance from Magic City to Seoul was closer than the distance from Magic City to Pengcheng. If something happened, the country would have a way to rescue him.

After all, there is a saying that the truth is often only within the range of the cannon, so Lin Zitai was confident at that time.

But now we have to step into the soil of the United States. The two countries are separated by more than thousands of miles, and there is also the Pacific Ocean.

It doesn't matter if you are called a coward, there is nothing wrong with being careful. (End of chapter)